Veradigm | MDRX - Cash And Equivalent


Veradigm reported $492.6M in Cash and Equivalent for its fiscal quarter ending in September of 2022.





Cash And Equivalent Change Date
Alcidion AUD 11.8M 2.84M Jun/2024
Ambu A/S DKK 735M 16M Dec/2025
Amplifon EUR 237.31M 5.38M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Centene USD 17.89B 830M Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Cigna USD 7.68B 1.65B Dec/2025
Coloplast 911M 497M Sep/2023
Computer Programs Systems USD 24.85M 4.93M Dec/2025
Convatec Group USD 64.7M 32.2M Dec/2024
CVS Health USD 8.45B 645M Dec/2025
Diasorin EUR 173.08M 3.51M Jun/2025
Elevance Health USD 9.49B 778M Dec/2025
General Electric Aerospace USD 12.39B 109M Dec/2025
Gulf Medical Proj AED 74.52M 101.52M Mar/2025
Humana USD 4.2B 1.19B Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 532.3M 65.8M Dec/2025
Maximus USD 137.59M 84.76M Dec/2025
McKesson USD 2.96B 1.05B Dec/2025
Med Life RON 185.35M 35.79M Sep/2025
Molina Healthcare USD 4.25B 27M Dec/2025
Omnicell USD 180.05M 218.95M Sep/2025
Oriola-kd EUR 107.6M 13.9M Sep/2025
Owens Minor USD 281.99M 249.15M Dec/2025
Quest Diagnostics USD 420M 12M Dec/2025
Rede D'or Sao Luiz BRL 3.71B 1.83B Dec/2025
Siemens Healthineers EUR 2.37B 30M Jun/2025
Sonova Holding CHF 413.9M 134.3M Jun/2023
Supermax Corporation Bhd MYR 855.25M 11.02M Sep/2025
UnitedHealth USD 28.12B 2.49B Dec/2025
Veeva Systems USD 1.42B 238.9M Dec/2025
Veradigm USD 492.6M 7.57M Sep/2022
Xerox USD 479M 30M Sep/2025